U.S. Court Dismisses Arm Allegation of Qualcomm Unit Violating License Agreement
By Sherry Qin
A U.S. court said Qualcomm's central processors are properly licensed under an agreement with Arm Holdings and rejected Arm's remaining claims.
The U.S. District Court for the District of Delaware dismissed Arm's claim that Nuvia, a startup that was acquired by Qualcomm in 2021, violated its license agreement with Arm, Qualcomm said in a statement Tuesday.
In December, a Delaware jury ruled that Qualcomm had a valid license to use Arm's basic chip architecture for central processors it developed with the acquisition of Nuvia.
When Qualcomm bought Nuvia for $1.4 billion, the smaller company was developing central processing chips for data centers based on Arm's architecture. Qualcomm abandoned that path after the acquisition, and adapted the chip designs Nuvia developed for power-sipping laptops that started to hit the market in 2024.
The ruling allowed Qualcomm to continue selling those chips, which are at the heart of a range of devices including Microsoft Surface laptops, without paying additional licensing fees.
Arm didn't immediately respond to a request for comment.
Qualcomm's separate lawsuit against Arm alleging breach of contract and a pattern of conduct in seeking to hinder innovation is ongoing and expected to go to trial in March 2026, Qualcomm said.
Write to Sherry Qin at sherry.qin@wsj.com
(END) Dow Jones Newswires
September 30, 2025 22:46 ET (02:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
10 Best Blue-Chip Stocks to Buy for the Long Term
